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The ESPN/ERA-EDTA registry
Few data are available regarding the epidemiology of end-
stage renal disease (ESRD) in children. The European
Society of Paediatric Nephrology (ESPN), in collaboration
with the European Renal Association–European Dialysis
and Transplant Association (ERA-EDTA), has recently
established a meta-registry of European paediatric patient
registries [1]. Thirty European countries reported individual
patient data with information on date of birth, gender, start
date renal replacement therapy (RRT), treatment modality
at the start, changes in treatment, and important events such as
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death and transfer out of registry. Here we provide the first
demographic information obtained by the ESPN/ERA-EDTA
registry, relating to the calendar year 2007, including data
from 28 countries.
Hungary provided data for 86%, and Russia for 50% of
the population; the demographic figures from these
countries were extrapolated accordingly. As Italy only
provided information on those starting on dialysis, this
country was omitted from the calculation of the
transplantation-specific incidence and prevalence. As the
majority of countries (Belarus, Croatia, Czech Republic,
Estonia, FYR of Macedonia, Hungary, Italy, Latvia,
Lithuania, Montenegro, Poland, Portugal, Russia, Serbia,
Slovakia, Slovenia, and the United Kingdom) collected
information mainly from paediatric centres, information on
individuals 15–17 years could be incomplete. In order to
provide a valid comparison between countries, reporting
has therefore been restricted to patients younger than
15 years of age.
Incidence was defined as the number of new patients
starting RRT in 2007, and the point prevalence was given
by the total number of patients on RRT on 31 December
2007 [2]. Both incidence and prevalence were expressed in
absolute numbers and per million age-related population
(pmarp). Furthermore, to allow calculations of the number
of children on RRT based on population data, results were
also expressed per million total population, including adults
(pmtp).
Incidence of paediatric RRT across Europe
In 2007, the overall incidence rate of RRT among children
under the age of 15 was 6.5 pmarp, which was 1.0 pmtp.
The median reported incidence by region/country was 6.5
pmarp (interquartile range 3.7–7.8). The incidence was
highest in adolescence (8.0 pmarp; age group 10–14 years),
lowest in mid-childhood (4.6 pmarp), and intermediate
(6.7 pmarp) in children younger than 5 years of age. RRT
incidence was almost 50% higher in males (7.5 pmarp) than
in females (5.4 pmarp). The modality-specific incidences
were 2.8 pmarp for peritoneal dialysis, 2.4 pmarp for
haemodialysis, 1.0 pmarp for pre-emptive transplantation
and unknown for 0.3 pmarp (Table 1).
Prevalence of paediatric RRT across Europe
The overall point prevalence of paediatric RRT on 31
December 2007 was 33.6 pmarp, which was 5.4 pmtp. The
median prevalence across countries and regions was 31.1
pmarp, with an interquartile range of 24.5 to 41.6 pmarp.
Prevalence increased more than threefold from the infant to
Table 1 Incidence of paediatric patients accepted for renal replace-
ment therapy (RRT) in 2007 and general population characteristics of
countries contributing 2007 data to the European Society for
Paediatric Nephrology/European Renal Association—European Dial-
ysis and Transplant Association (ESPN/ERA-EDTA) registry
Country RRT patients General population
0–14 years 0–14 years
Count pmarp Count
Austria 10 7.7 1,296,776
Belarus 10 7.0 1,421,557
Croatia 2 2.9 686,967
Czech Republic 9 6.1 1,478,219
Denmark 5 4.9 1,025,793
Estonia 0 0.0 199,223
Finland 11 12.3 897,885
France 77 6.5 11,767,559
FYR of Macedonia 3 7.9 381,868
Greece 13 8.1 1,598,665
Hungarya 3 2.3 1,306,536
Iceland 1 15.2 65,633
Italyb 35 4.2 8,350,585
Latviac 1 3.2 315,386
Lithuania 3 5.7 527,561
Montenegro 0 0 123,048
The Netherlands 22 7.5 2,947,170
Norway 3 3.3 906,655
Poland 41 6.9 5,961,618
Portugalc 16 9.8 1,633,245
Romania 8 2.4 3,298,815
Russiaa 81 7.8 10,426,340
Serbia 5 4.4 1,142,760
Slovakia 4 4.6 860,833
Slovenia 2 7.1 281,081
Spain, Andalusia 10 7.6 1,316,682
Spain, Aragon 2 11.7 170,569
Spain, Basque 1 3.7 271,786
Spain, Catalonia 4 3.8 1,046,915
Spain, Valencia 7 9.9 707,577
Sweden 11 7.1 1,545,660
United Kingdom 83 7.7 10,721,100
Total 483 6.5 74,682,067
Incident rates may vary over the years due to random variation
because of small numbers
a Assuming 86% coverage of general population for Hungary and 50%
coverage for Russia
b Pre-emptive transplantation not included
c Only patients from paediatric centres included
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Table 2 Prevalence of paediatric patients on renal replacement therapy (RRT) on 31 December 2007. Prevalence counts and prevalence per
million age-related population by age and gender in countries contributing 2007 data to the European Society for Paediatric Nephrology/European
Renal Association—European Dialysis and Transplant Association (ESPN/ERA-EDTA) data registry
Country Total (years) Age groups (years) Gender (years) Treatment modalityd (years)
RRT patients Males Females HD PD Tx
0–14 0–4 5–9 10–14 0–14 0–14 0–14 0–14 0–14
Count pmarp pmarp pmarp pmarp pmarp pmarp pmarp pmarp pmarp
Austria 54 41.6 17.5 50.3 54.3 49.6 33.3 2.3 3.9 35.5
Belarus 19 13.3 8.7 17.6 13.4 13.6 12.9 2.8 9.8 0.7
Croatia 19 27.7 14.6 17.5 47.4 31.2 23.9 2.9 11.6 13.1
Czech Republic 33 22.3 19.8 15.5 30.7 21.1 23.6 1.4 8.8 12.2
Denmark 38 37.0 15.2 38.4 56.0 45.7 28.0 3.9 1.9 31.2
Estonia 2 10.0 0.0 16.2 14.8 9.8 10.3 0 10.0 0
Finland 83 92.4 79.3 93.8 103.0 102.5 81.9 1.1 10.0 81.3
France 401 34.1 15.5 29.3 57.9 41.7 26.1 5.0 2.3 26.4
FYR of Macedonia 7 18.3 0.0 16.1 34.6 25.4 10.8 0 18.3 0
Greece 46 28.8 9.3 33.1 43.9 34.0 23.2 5.6 10.0 13.1
Hungarya 37 28.3 7.2 21.7 52.5 38.8 17.3 1.5 3.1 23.7
Iceland 2 30.5 0.0 94.1 0.0 0.0 62.1 0 0 30.5
Italyb 247 29.6 18.2 31.8 38.7 33.8 25.1 2.6 7.7 na
Latviac 2 6.3 0.0 10.5 8.9 6.2 6.5 0 6.3 0
Lithuania 17 32.2 19.7 23.8 48.2 44.4 19.4 11.4 9.5 11.4
Montenegro 1 8.1 0.0 24.7 0.0 15.7 0.0 0 0 8.1
The Netherlands 131 44.4 18.8 45.6 68.2 52.4 36.1 7.8 6.4 30.2
Norway 42 46.3 24.0 39.9 73.2 56.0 36.2 1.1 0 45.2
Poland 230 38.6 22.7 38.7 51.2 45.2 29.3 6.5 18.6 12.4
Portugalc 64 39.2 22.1 45.5 49.9 47.7 30.2 1.2 19.6 18.4
Romania 35 10.6 1.9 7.3 21.9 8.9 12.4 5.8 4.2 0.6
Russiaa 168 16.1 5.5 14.0 29.1 16.3 15.9 5.5 3.7 6.6
Serbia 28 24.5 5.4 27.4 39.5 32.4 16.2 6.1 1.8 16.6
Slovakia 23 26.7 7.6 25.8 43.1 27.2 26.2 4.6 11.6 10.5
Slovenia 6 21.3 10.9 33.0 20.4 27.7 14.6 7.1 10.7 3.6
Spain, Andalusia 41 31.1 6.8 25.7 60.4 33.9 28.2 1.5 2.3 27.3
Spain, Aragon 6 35.2 34.0 17.9 53.8 45.6 24.2 0 0 35.2
Spain, Basque 26 95.7 20.0 134.0 145.5 100.3 90.8 3.7 7.4 84.6
Spain, Catalonia 48 45.8 31.0 46.9 62.7 55.6 35.4 5.7 1.9 38.2
Spain, Valencia 29 41.0 32.8 34.6 55.9 54.9 26.2 7.1 4.2 29.7
Sweden 75 48.5 30.8 44.5 68.5 55.5 41.2 1.3 5.2 42.1
United Kingdom 552 51.5 23.1 46.7 83.4 60.8 41.1 6.8 11.8 24.0
Total 2512 33.6 16.4 32.2 51.5 39.2 27.5 4.8 7.4 20.1e
HD haemodialysis, PD peritoneal dialysis, Tx transplantation
a Assuming 86% coverage of the general population for Hungary, 50% for Russia
b Pre-emptive transplantation not included
c Only patients from paediatric centres included
d Patients with unknown treatment modalities excluded
e Patients from Italy excluded
2 Prevalence of paediatric patients o renal r placement
therapy (RRT) on 31 December 2007. P evalent counts and
prevalence per million ag -related population by ge and gender in
countries contributing 2007 data to the Europea Society for Paediatric
Nephrology/European Renal Ass ciation—European Dialysis and
Transplant ssoci tion (ESPN/ERA-EDTA) data registry
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the adolescent age group. More than half of the patients had
a functioning kidney allograft (20.1 pmarp), whereas 7.4
patients pmarp were on peritoneal dialysis and 4.8 on
haemodialysis. Treatment modality was unknown in 1.4
patients pmarp (Table 2).
Conclusions
The data contributed by 32 registries from 28 European
countries by the end of 2007 allowed us to calculate current
demographic figures for paediatric RRT across the continent.
Both incidence and prevalence of RRT are about 20 times
lower in children compared with adults [3]. In comparison to
the last demographic report of the former EDTA registry
14 years ago [4], we found nearly threefold higher incidence
and prevalence of RRT among children aged younger than
15 years. This difference is likely to be due to the critical
underreporting to the previous registry based on question-
naire collection from individual centres. However, it may in
some part also reflect a recent achievement of RRT
programmes for all children in many countries and an
increasing acceptance and survival of infants and children
with multiple comorbidities in paediatric RRT programmes,
resulting in a truly increased incidence and prevalence of
RRT. Nevertheless, information extracted from the report on
paediatric RRT of the current ERA-EDTA registry [5], which
comprised data collected in 2000 from 11 western European
countries, showed that children younger than 15 years had a
very similar incidence and slightly higher prevalence
compared with data presented in this report.
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